Market Research Logo

Europe HIV Epidemiology and Patient Flow Analysis - 2017

Europe HIV Epidemiology and Patient Flow Analysis - 2017

Fore Pharma announced the results of its HIV patients study in a new report ‘Europe HIV Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into HIV epidemiology, HIV diagnosed patients, and HIV treatment rate for EU5 pharmaceutical markets. The study measures key indicators such as prevalence of HIV derived from epidemiological analysis, percentage of patients diagnosed with HIV, and percentage of patients treated with a therapy.

The study helps executives estimate HIV market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of HIV prevalence, HIV diagnosis rate, and HIV treatment rate for the period 2016 - 2025. The information is presented by leading geographies including Germany, France, Spain, Italy, and UK. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.

Key Features of the Report:

  • HIV Patient Flow
  • HIV Prevalence
  • HIV Diagnosed Patients
  • HIV Treated Patients


1. HIV: Disease Definition
2. HIV Patient Flow in Europe
2A. HIV Prevalence in Europe
2B. HIV Diagnosed Patients in Europe
2C. HIV Treated Patients in Europe
3. HIV Patient Flow in Germany
3A. HIV Prevalence in Germany
3B. HIV Diagnosed Patients in Germany
3C. HIV Treated Patients in Germany
4. HIV Patient Flow in France
4A. HIV Prevalence in France
4B. HIV Diagnosed Patients in France
4C. HIV Treated Patients in France
5. HIV Patient Flow in Spain
5A. HIV Prevalence in Spain
5B. HIV Diagnosed Patients in Spain
5C. HIV Treated Patients in Spain
6. HIV Patient Flow in Italy
6A. HIV Prevalence in Italy
6B. HIV Diagnosed Patients in Italy
6C. HIV Treated Patients in Italy
7. HIV Patient Flow in UK
7A. HIV Prevalence in UK
7B. HIV Diagnosed Patients in UK
7C. HIV Treated Patients in UK
8. Research Methodology
List of Tables
Table 1: HIV Patient Flow in Europe, 2016
Table 2: HIV Patient Flow Forecast in Europe, 2016 - 2025
Table 3: HIV Patient Flow in Germany, 2016
Table 4: HIV Patient Flow Forecast in Germany, 2016 - 2025
Table 5: HIV Patient Flow in France, 2016
Table 6: HIV Patient Flow Forecast in France, 2016 - 2025
Table 7: HIV Patient Flow in Spain, 2016
Table 8: HIV Patient Flow Forecast in Spain, 2016 - 2025
Table 9: HIV Patient Flow in Italy, 2016
Table 10: HIV Patient Flow Forecast in Italy, 2016 - 2025
Table 11: HIV Patient Flow in UK, 2016
Table 12: HIV Patient Flow Forecast in UK, 2016 - 2025
List of Figures
Figure 1: HIV Patient Flow in Europe, 2016
Figure 2: HIV Patient Flow Forecast in Europe, 2016 - 2025
Figure 3: HIV Patient Flow in Germany, 2016
Figure 4: HIV Patient Flow Forecast in Germany, 2016 - 2025
Figure 5: HIV Patient Flow in France, 2016
Figure 6: HIV Patient Flow Forecast in France, 2016 - 2025
Figure 7: HIV Patient Flow in Spain, 2016
Figure 8: HIV Patient Flow Forecast in Spain, 2016 - 2025
Figure 9: HIV Patient Flow in Italy, 2016
Figure 10: HIV Patient Flow Forecast in Italy, 2016 - 2025
Figure 11: HIV Patient Flow in UK, 2016
Figure 12: HIV Patient Flow Forecast in UK, 2016 - 2025

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report